Senior Financial Analyst, Oncology & INTO R&D

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Finance

Finance Business Partners

Professional

Raritan, New Jersey, United States of America, Spring House, Pennsylvania, United States of America, Titusville, New Jersey, United States of America

Johnson & Johnson Innovative Medicine is recruiting for Senior Financial Analyst, Global Oncology and Interventional Oncology (INTO) R&D supporting Discovery & Early Development. This position can be based in New Jersey (Raritan, Titusville) or Pennsylvania (Spring House) and may require up to 10% domestic travel.

The Senior Financial Analyst will provide financial leadership, support, and analysis to the Discovery & Early Development Oncology and INTO Portfolio. The position will own and manage key upcoming assets in Discovery & Early Development by collaborating with senior business partners to live into financial commitments and by influencing decision making aligned with TA strategy. This individual will also lead the overall Portfolio Valuations exercise for Oncology including framing and communicating to Senior Leaders in IM R&D.

• Provide robust financial support to Oncology Discovery/ED VP through owning and leading the forecasting and quarter close processes for the Discovery/ED Portfolio
• Lead financial support for Compound Development Team (CDT) and New Molecular Entity (NME) governance reviews with the Senior Leadership Team (SLT)
• Partner with the global innovation centers to forecast deal model financials and influence contract language on behalf of IM R&D
• Lead finance activities (i.e. Joint Finance Committee, External Forecasting & Close, etc.) on behalf of IM R&D for several external collaborations
• Lead overall Long Range Financial Oncology Portfolio Valuations including shaping and framing strategic insights to senior leaders
• Develop and lead Senior Management presentations through concise framing while providing transparency regarding key decision points, tradeoffs, and risk & opportunities to the plan
• Demonstrate strong financial leadership by providing recommendations for improving the quality & value of financial information supplied to senior management to support decision making

• A minimum of a Bachelor’s degree is required, preferably with a major in Accounting or Finance.
• MBA, CPA, CMA, or other financial certifications is preferred.
• A minimum of three (3) years finance or related business experience is required.
• Candidate must possess strong communication, interpersonal, and problem solving skills.
• Candidate must demonstrate strong financial analysis competencies and have a proven ability to think analytically and work collaboratively.
• The ability to think creatively and work in a team environment is required.
• The ability to effectively take on leadership roles in various functions is required.
• Must work well in a fast-paced environment and be able to recommend and implement process improvements, work independently and handle several tasks simultaneously.
• This position requires a highly motivated individual with intellectual curiosity and proven leadership skills.
• This position can be Spring House, PA, Raritan, NJ, or Titusville, NJ. This role may require up to 10% travel.

$79,000.00 - $